Home Newsletters Mammary Cell News Triple-Negative Breast Cancer Brain Metastasis: An Update on Druggable Targets, Current Clinical...

Triple-Negative Breast Cancer Brain Metastasis: An Update on Druggable Targets, Current Clinical Trials, and Future Treatment Options

0
The authors describe ongoing clinical trials on druggable targets in TNBC-brain metastasis (BM) for a more targeted treatment and introduce the obstacles hindering drug delivery to the brain, bringing strategies and advancing knowledge for future steps in the treatment of patients with TNBC-BM.
[Drug Discovery Today]

Sorry, but the selected Zotpress account can't be found.

AbstractGraphical Abstract
Exit mobile version